Fostemsavir characteristics
Learn more about the key attributes and core benefits of RUKOBIA based on the Phase III BRIGHTE data.
Story of Fostemsavir
The development of fostemsvir has been many years in the making. Here we describe its journey from conception to development. phase clinicals, and EMA and FDA approval
Mechanism of Action
Entry of the HIV into a target cell occurs through a process of 3 main steps. HIV entry inhibitors are varied in their point of action. Here we detail where the different entry inhibitors act and if they are pre attachment of post attachment. Fostemsavir has a new mechanism of action that is able tobind onto gp120, to prevent HIV attachment and entry.